Earth Science Tech Inc. (ETST) Gains Competitive Edge in

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
333
Earth Science Tech Inc. (ETST) Gains Competitive Edge in Hemp-Derived CBD Market by Shipping Legally to All 50 States

- Since its offerings are derived from hemp and not marijuana, Earth Science Tech’s products are fully compliant with the 2018 Farm Bill
- Earth Science Tech offers medical, recreational and industrial hemp through its wholly owned subsidiaries
- Each batch of the company’s CBD oil meets the strictest quality standards, positioning its offerings among the highest-quality products on the market

Earth Science Tech Inc. (OTCQB: ETST), an innovative biotechnology company operating in the fields of hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and development, is securing a commanding position in the burgeoning cannabis sector through its innovative approach and overall compliance with the 2018 Farm Bill.

Because the company’s offerings are derived from hemp and not marijuana, the products are fully compliant with the federal Farm Bill. This compliance allows the company a significant edge over competitors, because it can legally ship its Full Spectrum CBD products to all 50 states.

Earth Science Tech pairs this availability with a laser-like focus on product quality. Each batch of CBD oil is tested to ensure pharmacy-grade quality standards. As a result, the company offers some of the highest-purity and quality full-spectrum cannabinoids on the market.

Widening its distribution and industry reach, Earth Science Tech offers medical, recreational and industrial hemp through its multiple wholly owned subsidiary companies. Canna Inno Laboratories Inc. allows Earth Science Tech access to Canadian government funding and advancements gleaned from product research and development via grants offered to pharmaceutical innovators. Cannabis Therapeutics Inc. was formed as an emerging biotechnology company and is poised to become a global leader in cannabinoid research and development.

Earth Science Tech offers several variations of its High Grade Full Spectrum Cannabinoid products, including CBD Hemp Oil, CBD Capsules and CBD Pets. These products use hemp obtained through the company’s super-critical CO2 extraction to ensure the highest quality of cannabinoids and maintain all naturally occurring therapeutic properties. In the health and wellness industry, hemp products are increasingly sought-after for their incredible health benefits.

Hemp seeds (http://nnw.fm/R4KTy) are “exceptionally nutritious and rich in healthy fats, protein, and various minerals.” They make for an excellent protein source, as well as a great source of vitamin E and minerals such as phosphorus, potassium, sodium, magnesium, sulfur, calcium, iron and zinc. Earth Science Tech’s hemp products offer consumers many health benefits, including reduced risk of heart disease, digestive aid and dry skin relief.

Because of its increased revenues and income stream opportunities, Earth Science Tech is ideally poised in multiple markets that are experiencing rapid growth. The company’s diverse portfolio and pipeline encompass a wide range of cutting-edge products and devices set to expand its leadership in various market sectors.

For more information, visit the company’s website at www.EarthScienceTech.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Earth Science Tech, Inc. (ETST) Stock Research Links

ETST Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles